214
views
0
recommends
+1 Recommend
0 collections
    12
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Mitochondrial dysfunction is a major factor in heart failure (HF). A pronounced variability of mitochondrial electron transport chain (ETC) defects is reported to occur in severe acquired cardiomyopathies without a consistent trend for depressed activity or expression. The aim of this study was to define the defect in the integrative function of cardiac mitochondria in coronary microembolization-induced HF.

          Methods and results

          Studies were performed in the canine coronary microembolization-induced HF model of moderate severity. Oxidative phosphorylation was assessed as the integrative function of mitochondria, using a comprehensive variety of substrates in order to investigate mitochondrial membrane transport, dehydrogenase activity and electron-transport coupled to ATP synthesis. The supramolecular organization of the mitochondrial ETC also was investigated by native gel electrophoresis. We found a dramatic decrease in ADP-stimulated respiration that was not relieved by an uncoupler. Moreover, the ADP/O ratio was normal, indicating no defect in the phosphorylation apparatus. The data point to a defect in oxidative phosphorylation within the ETC. However, the individual activities of ETC complexes were normal. The amount of the supercomplex consisting of complex I/complex III dimer/complex IV, the major form of respirasome considered essential for oxidative phosphorylation, was decreased.

          Conclusions

          We propose that the mitochondrial defect lies in the supermolecular assembly rather than in the individual components of the ETC.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          Supercomplexes in the respiratory chains of yeast and mammalian mitochondria.

          Around 30-40 years after the first isolation of the five complexes of oxidative phosphorylation from mammalian mitochondria, we present data that fundamentally change the paradigm of how the yeast and mammalian system of oxidative phosphorylation is organized. The complexes are not randomly distributed within the inner mitochondrial membrane, but assemble into supramolecular structures. We show that all cytochrome c oxidase (complex IV) of Saccharomyces cerevisiae is bound to cytochrome c reductase (complex III), which exists in three forms: the free dimer, and two supercomplexes comprising an additional one or two complex IV monomers. The distribution between these forms varies with growth conditions. In mammalian mitochondria, almost all complex I is assembled into supercomplexes comprising complexes I and III and up to four copies of complex IV, which guided us to present a model for a network of respiratory chain complexes: a 'respirasome'. A fraction of total bovine ATP synthase (complex V) was isolated in dimeric form, suggesting that a dimeric state is not limited to S.cerevisiae, but also exists in mammalian mitochondria.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Respiratory complex III is required to maintain complex I in mammalian mitochondria.

            A puzzling observation in patients with oxidative phosphorylation (OXPHOS) deficiencies is the presence of combined enzyme complex defects associated with a genetic alteration in only one protein-coding gene. In particular, mutations in the mtDNA encoded cytochrome b gene are associated either with combined complex I+III deficiency or with only complex III deficiency. We have reproduced the combined complex I+III defect in mouse and human cultured cell models harboring cytochrome b mutations. In both, complex III assembly is impeded and causes a severe reduction in the amount of complex I, not observed when complex III activity was pharmacologically inhibited. Metabolic labeling in mouse cells revealed that complex I was assembled, although its stability was severely hampered. Conversely, complex III stability was not influenced by the absence of complex I. This structural dependence among complexes I and III was confirmed in a muscle biopsy of a patient harboring a nonsense cytochrome b mutation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients.

              Mutations in the human TAZ gene are associated with Barth Syndrome, an often fatal X-linked disorder that presents with cardiomyopathy and neutropenia. The TAZ gene encodes Tafazzin, a putative phospholipid acyltranferase that is involved in the remodeling of cardiolipin, a phospholipid unique to the inner mitochondrial membrane. It has been shown that the disruption of the Tafazzin gene in yeast (Taz1) affects the assembly and stability of respiratory chain Complex IV and its supercomplex forms. However, the implications of these results for Barth Syndrome are restricted due to the additional presence of Complex I in humans that forms a supercomplex with Complexes III and IV. Here, we investigated the effects of Tafazzin, and hence cardiolipin deficiency in lymphoblasts from patients with Barth Syndrome, using blue-native polyacrylamide gel electrophoresis. Digitonin extraction revealed a more labile Complex I/III(2)/IV supercomplex in mitochondria from Barth Syndrome cells, with Complex IV dissociating more readily from the supercomplex. The interaction between Complexes I and III was also less stable, with decreased levels of the Complex I/III(2) supercomplex. Reduction of Complex I holoenzyme levels was observed also in the Barth Syndrome patients, with a corresponding decrease in steady-state subunit levels. We propose that the loss of mature cardiolipin species in Barth Syndrome results in unstable respiratory chain supercomplexes, thereby affecting Complex I biogenesis, respiratory activities and subsequent pathology.
                Bookmark

                Author and article information

                Journal
                Cardiovasc Res
                cvrese
                cardiovascres
                Cardiovascular Research
                Oxford University Press
                0008-6363
                1755-3245
                1 October 2008
                18 August 2008
                18 August 2008
                : 80
                : 1
                : 30-39
                Affiliations
                [1 ]Department of Medicine, School of Medicine, Case Western Reserve University , 10900 Euclid Avenue, Cleveland 44106-4981, OH, USA
                [2 ]Department of Pharmacology, Case Western Reserve University , Cleveland, OH, USA
                [3 ]Department of Nutrition, Case Western Reserve University , Cleveland, OH, USA
                [4 ]Department of Physiology and Biophysics, Case Western Reserve University , Cleveland, OH, USA
                [5 ]Division of Cardiology, Department of Medicine, University of Maryland-Baltimore , Baltimore, MD, USA
                [6 ]Department of Medicine, Henry Ford Hospital, Henry Ford Heart and Vascular Institute , Detroit, MI, USA
                Author notes
                [* ]Corresponding author. Tel: +1 216 368 3147; fax: +1 216 368 5162. E-mail address: charles.hoppel@ 123456case.edu
                Article
                cvn184
                10.1093/cvr/cvn184
                2533423
                18710878
                10dc2fd9-3769-4090-bf7c-f4b9b2efaa64
                Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

                The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org.

                History
                : 29 January 2008
                : 23 June 2008
                : 26 June 2008
                Categories
                Original Articles
                Custom metadata
                Time for primary review: 19 days

                Cardiovascular Medicine
                mitochondria,oxidative phosphorylation,heart failure,respirasomes,electron transport chain complexes

                Comments

                Comment on this article